本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corcept医疗

40.83
-0.1400-0.34%
盘后40.74-0.0900-0.22%17:58 EST
成交量:85.16万
成交额:3,444.47万
市值:42.95亿
市盈率:46.75
高:41.00
开:40.59
低:39.66
收:40.97
52周最高:117.33
52周最低:32.99
股本:1.05亿
流通股本:8,687.53万
量比:0.82
换手率:0.98%
股息:- -
股息率:- -
每股收益(TTM):0.8735
每股收益(LYR):1.23
净资产收益率:16.70%
总资产收益率:5.10%
市净率:6.80
市盈率(LYR):33.20

数据加载中...

公司资料

公司名字:
Corcept医疗
交易所:
NASDAQ
成立时间:
1998
员工人数:
500
公司地址:
101 Redwood Shores Parkway,Redwood City,California,United States
邮编:
94065
电话:
传真:
- -
简介:
Corcept Therapeutics Incorporated于1998年5月13日在特拉华州注册成立。该公司是一家商业阶段公司,从事发现和开发药物,通过调节激素皮质醇的作用来治疗严重的内分泌、肿瘤、代谢和神经系统疾病。

董事

名称
职位
James N. Wilson
Chairman of the Board
Joseph K. Belanoff
Director,Chief Executive Officer and President
Daniel N. Swisher, Jr.
Director
David L. Mahoney
Director
G. Leonard Baker, Jr.
Director
Gregg Alton
Director
Joshua M. Murray
Director
Kimberly Park
Director

股东

名称
职位
Joseph K. Belanoff
Director,Chief Executive Officer and President
Atabak Mokari
Chief Financial Officer and Treasurer
Charles Robb
Chief Business Officer and Secretary
Hazel Hunt
Chief Scientific Officer
Joseph D. Lyon
Chief Accounting and Technology Officer
Sean Maduck
President, Corcept Endocrinology
William Guyer
Chief Development Officer